For example, the Bromodomain and Extra-Terminal motif inhibitors (BET inhibitors; such as JQ1) designed to interfere with the functions of bromodomain-containing proteins like BRD4 have shown promise in several pre-clinical models of cancer, although their efficacy in a clinical setting is still unknown25,70. Here, DNER is linked to cancer.